Research Paper
Asymmetric bolaamphiphiles from vernonia oil designed for drug delivery
Article first published online: 25 JAN 2010
DOI: 10.1002/ejlt.200900107
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Issue
1438-9312/asset/cover.gif?v=1&s=334b63d1d783c28d040f5a3e63113748f2b3bec2)
European Journal of Lipid Science and Technology
Special Issue: Oil and fats as renewable resources for the chemical industry
Volume 112, Issue 1, pages 137–151, No. 1 January 2010
Additional Information
How to Cite
Grinberg, S., Kipnis, N., Linder, C., Kolot, V. and Heldman, E. (2010), Asymmetric bolaamphiphiles from vernonia oil designed for drug delivery. Eur. J. Lipid Sci. Technol., 112: 137–151. doi: 10.1002/ejlt.200900107
Publication History
- Issue published online: 25 JAN 2010
- Article first published online: 25 JAN 2010
- Manuscript Accepted: 7 OCT 2009
- Manuscript Received: 6 MAY 2009
Funded by
- Applied Research Fund for Biotechnology Research of BG Negev Technologies Ltd., Ben-Gurion University
- United States–Israel Binational Science Foundation. Grant Number: 2003153
Keywords:
- Acetylcholine;
- Bolaamphiphiles;
- Drug delivery;
- Vernonia oil;
- Vesicles
Abstract
Throughout the ages, fats, oils and their chemical derivatives have been used in a variety of medical applications, but currently they are becoming important as components in drug delivery systems. Liposomes (vesicles from phospholipids) are among the lipid-based delivery systems that have been most extensively studied. However, targeting of liposomes to specific tissues is still problematic, and attempts to overcome these limitations include developments in nano-sized monolayer vesicles made of bolaamphiphiles (compounds containing two hydrophilic headgroups at each end of an alkyl chain). This paper describes bolaamphiphile synthesis and characterization of the nano-sized vesicles formed from the bolaamphiphiles with potential application for targeted drug delivery to the brain. The starting material for the synthesis is vernonia oil (or its fatty acids or methyl esters), which is a naturally epoxidized triacylglycerol obtained from the seeds of Vernonia galamensis. The targeting mechanism is based on the hydrolysis of the amphiphile's headgroup by an enzyme abundant in the target tissue, with subsequent release of the encapsulated drug at the target site. Preliminary experiments in mice demonstrated that the marker FITC-dextran, which normally does not penetrate the blood brain barrier, is delivered into the brain when encapsulated in these vesicles.

1438-9312/asset/olbannerleft.gif?v=1&s=f532c5681777079b8fadecd0c5eedd9d5efe01cc)
1438-9312/asset/olbannerright.gif?v=1&s=633e89897e2319644d98f23eac90a26e834f6375)